Saturday, March 2, 2024

CATEGORY

Roche

The First and Only Pharmaceutical Food Allergy Therapy Xolair Gains New FDA Approval

As it nears the end of its patent life, Roche and Novartis' Xolair for food allergy is making significant strides by gaining groundbreaking new...

Roche Terminates Collaboration with Repare Therapeutics for ATR Inhibitor Camonsertib Development

Roche has concluded its global license and collaboration agreement with Repare Therapeutics Inc. concerning the development and commercialization of camonsertib (RP-3500). The rights to...

Partnership to Revolutionize Digital Pathology and Precision Medicine with AI by Roche and PathAI

Roche has unveiled a landmark partnership with PathAI to enhance digital pathology with artificial intelligence (AI), targeting companion diagnostics. This collaboration is set to...

Cancer Treatment Tecentriq Granted Approval by the European Union for Subcutaneous Formulation

Roche has gained approval from the European Union for a subcutaneous formulation of its cancer treatment Tecentriq (atezolizumab). This new version is designed to...

Roche’s Merger Deal: Acquiring Carmot Therapeutics’ Potent Assets in Diabetes and Obesity

Roche, a global leader in healthcare, has announced a definitive merger agreement with Carmot Therapeutics, a prominent US-based biotech company specializing in metabolic disease...

Roche Broadens Hepatitis Diagnostic Portfolio for Enhanced Patient Monitoring and Diagnosis

Roche, a leader in diagnostic solutions, has launched Elecsys® HBeAg quant, a breakthrough immunoassay designed to diagnose and monitor hepatitis B (HBV) infection efficiently....

Roche Unveils Hepatitis E Virus Serology Tests in Line with WHO’s Essential Diagnostics List

Roche has taken a significant stride in diagnostic healthcare by unveiling the Elecsys® Anti-HEV IgM and Anti-HEV IgG immunoassays designed to detect hepatitis E...

EU’s CHMP Recommends Roche’s Immunotherapy Tecentriq Subcutaneous Injection for Diverse Cancer Types

Roche has received a positive recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for the approval of subcutaneous...

FDA Grants Breakthrough Designation to Roche’s Elecsys NfL Test for Multiple Sclerosis

Roche's Elecsys Neurofilament Light Chain (NfL) test, designed for Multiple Sclerosis (MS), has received Breakthrough Device Designation from the U.S. Food and Drug Administration...

Roche to Showcase Robust MS and NMOSD Real-World Data at ECTRIMS-ACTRIMS 2023

Roche to unveil new clinical and real-world data at ECTRIMS-ACTRIMS 2023 demonstrating the robustness of long-term results in MS and NMOSD. Roche is set to...

Latest news

Sticky Image